HeartBeam Ranks Second Globally in 12-Lead ECG Innovation, Signaling Shift Toward Portable Cardiac Diagnostics

HeartBeam has been ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, according to PatentVest's "Total Cardiac Intelligence" report, trailing only GE Healthcare in this global assessment of portable cardiac diagnostics innovation. The recognition highlights the company's growing influence in the next generation of cardiac monitoring technology and underscores the rapid maturation of its proprietary synthesis-ECG system, which captures the heart's electrical signals in three noncoplanar dimensions and synthesizes them into a 12-lead ECG.

This unique approach allows physicians to obtain cardiologist-level ECG data from compact devices that can be used by patients or clinicians far from traditional hospital settings. In doing so, HeartBeam is addressing one of modern medicine's most persistent challenges: delivering high-quality cardiac monitoring for arrhythmia assessment wherever patients are. The company is cleared for arrhythmia today, with ischemia monitoring as a future goal. HeartBeam is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions, with this platform technology designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence.

Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care—all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement, with additional information about the company's technology and approach available at https://www.HeartBeam.com. Additional news and updates relating to HeartBeam are available through the company's newsroom at https://ibn.fm/BEAT.

The implications of this recognition extend beyond corporate achievement to potential healthcare transformation. As cardiac monitoring technology becomes more portable and accessible, patients in remote or underserved areas could receive the same quality of cardiac assessment as those in major medical centers. This advancement could lead to earlier detection of cardiac issues, more timely interventions, and potentially reduced healthcare costs by minimizing unnecessary hospital visits while ensuring appropriate care reaches those who need it most. The ranking validates HeartBeam's technological approach at a critical moment when healthcare systems worldwide are seeking more efficient, accessible cardiac monitoring solutions that can extend beyond traditional clinical environments.